Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging |
| |
| Authors: | Srila Samphao M.D. Amanda J. Wheeler M.D. Elizabeth Rafferty M.D. James S. Michaelson Ph.D. Michelle C. Specht M.D. Michele A. Gadd M.D. Kevin S. Hughes M.D. Barbara L. Smith M.D. Ph.D. |
| |
| Affiliation: | aDepartment of Surgery, Division of Surgical Oncology, Massachusetts General Hospital/Harvard Medical School, Yawkey 9A, 55 Fruit St., Boston, MA 02114, USA;bDepartment of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA;cDepartment of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA |
| |
| Abstract: | ![]()
BackgroundThe impact of newer breast imaging technologies and genetic testing on the detection of breast cancer in women age 40 and younger remains unknown.MethodsA records review identified 628 women age 40 and younger diagnosed with breast cancer from 1996 to 2008. Patient and tumor characteristics, means of diagnosis, imaging results, and genetic testing were examined.ResultsTumors were first detected by self-examination in 71%, with a median invasive tumor size of 2.0 cm. Imaging performed at or after diagnosis visualized most tumors; mammography visualized 86%, magnetic resonance imaging (MRI) visualized 96%, and mammography plus MRI visualized more than 98% of tumors. For 81% of patients, the mammogram at diagnosis was their first mammogram. Although 50% had a family history of breast or ovarian cancer, few underwent genetic testing before their cancer diagnosis; 61 of 247 (25%) ultimately tested had a BRCA mutation.ConclusionsBetter use of genetic testing, mammography, and MRI could improve breast cancer detection in young women. |
| |
| Keywords: | Breast cancer Young women Genetic testing Digital mammography Magnetic resonance imaging |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
